Financhill
Buy
54

CZA Quote, Financials, Valuation and Earnings

Last price:
$106.90
Seasonality move :
2.6%
Day range:
$106.22 - $106.67
52-week range:
$90.68 - $113.72
Dividend yield:
1.24%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
53.5K
Avg. volume:
4.1K
1-year change:
16.05%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Invesco Zacks Mid-Cap ETF has -- downside to fair value with a price target of -- per share.

CZA vs. S&P 500

  • Over the past 5 trading days, Invesco Zacks Mid-Cap ETF has overperformed the S&P 500 by 0.79% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Invesco Zacks Mid-Cap ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Invesco Zacks Mid-Cap ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Invesco Zacks Mid-Cap ETF reported revenues of --.

Earnings Growth

  • Invesco Zacks Mid-Cap ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Invesco Zacks Mid-Cap ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-18 2024-01-18 2024-01-18
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-01-18 2022-01-18 2023-01-18 2024-01-18
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-18 2024-01-18 2024-01-18
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
CZA
Sector
Market Cap
--
--
Price % of 52-Week High
93.8%
--
Dividend Yield
1.24%
--
Shareholder Yield
--
--
1-Year Price Total Return
16.06%
--
Beta (5-Year)
0.990
--
Dividend yield:
1.24%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $104.24
200-day SMA
Buy
Level $103.37
Bollinger Bands (100)
Sell
Level 104.68 - 110.74
Chaikin Money Flow
Buy
Level 2.7M
20-day SMA
Buy
Level $104.85
Relative Strength Index (RSI14)
Buy
Level 53.62
ADX Line
Buy
Level 33.51
Williams %R
Sell
Level 0
50-day SMA
Sell
Level $108.59
MACD (12, 26)
Sell
Level -1.13
25-day Aroon Oscillator
Sell
Level -76
On Balance Volume
Neutral
Level 4.1M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, CZA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CZA average analyst price target in the past 3 months is --.

  • Where Will Invesco Zacks Mid-Cap ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Invesco Zacks Mid-Cap ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Invesco Zacks Mid-Cap ETF?

    Analysts are divided on their view about Invesco Zacks Mid-Cap ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Invesco Zacks Mid-Cap ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Invesco Zacks Mid-Cap ETF's Price Target?

    The price target for Invesco Zacks Mid-Cap ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CZA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Invesco Zacks Mid-Cap ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CZA?

    You can purchase shares of Invesco Zacks Mid-Cap ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Invesco Zacks Mid-Cap ETF shares.

  • What Is The Invesco Zacks Mid-Cap ETF Share Price Today?

    Invesco Zacks Mid-Cap ETF was last trading at $106.90 per share. This represents the most recent stock quote for Invesco Zacks Mid-Cap ETF. Yesterday, Invesco Zacks Mid-Cap ETF closed at $106.67 per share.

  • How To Buy Invesco Zacks Mid-Cap ETF Stock Online?

    In order to purchase Invesco Zacks Mid-Cap ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Will T-Mobile Stock Recover?
Will T-Mobile Stock Recover?

Last year was a stellar year for telecom giant T-Mobile…

Why Is Stanley Druckenmiller Buying Citigroup?
Why Is Stanley Druckenmiller Buying Citigroup?

As recently as 2020, few analysts could have predicted that…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 112x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
NUTX alert for Jan 17

Nutex Health [NUTX] is up 2.83% over the past day.

Buy
53
QMCO alert for Jan 17

Quantum [QMCO] is down 15.61% over the past day.

Sell
34
NGVT alert for Jan 17

Ingevity [NGVT] is up 1.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock